Angucyclines: Biosynthesis, mode-of-action, new natural products, and synthesis
Top Cited Papers
- 21 December 2011
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 29 (2), 264-325
- https://doi.org/10.1039/c1np00068c
Abstract
Covering: 1997 to 2010 The angucycline group is the largest group of type II PKS-engineered natural products, rich in biological activities and chemical scaffolds. This stimulated synthetic creativity and biosynthetic inquisitiveness. The synthetic studies used five different strategies, involving Diels-Alder reactions, nucleophilic additions, electrophilic additions, transition-metal mediated cross-couplings and intramolecular cyclizations to generate the angucycline frames. Biosynthetic studies were particularly intriguing when unusual framework rearrangements by post-PKS tailoring oxidoreductases occurred, or when unusual glycosylation reactions were involved in decorating the benz[a]anthracene-derived cores. This review follows our previous reviews, which were published in 1992 and 1997, and covers new angucycline group antibiotics published between 1997 and 2010. However, in contrast to the previous reviews, the main focus of this article is on new synthetic approaches and biosynthetic investigations, most of which were published between 1997 and 2010, but go beyond, e.g. for some biosyntheses all the way back to the 1980s, to provide the necessary context of information.Keywords
This publication has 227 references indexed in Scilit:
- Total Synthesis of Jadomycin A and a Carbasugar Analogue of Jadomycin BAngewandte Chemie, 2010
- Cloning and Characterization of the Ravidomycin and Chrysomycin Biosynthetic Gene ClustersChemBioChem, 2010
- GilR, an Unusual Lactone‐Forming Enzyme Involved in Gilvocarcin BiosynthesisChemBioChem, 2009
- Elucidation of Oxygenation Steps during Oviedomycin Biosynthesis and Generation of Derivatives with Increased Antitumor ActivityChemBioChem, 2009
- Inactivation of the Ketoreductase gilU Gene of the Gilvocarcin Biosynthetic Gene Cluster Yields New Analogues with Partly Improved Biological ActivityChemBioChem, 2009
- Natural‐Product Sugar Biosynthesis and Enzymatic GlycodiversificationAngewandte Chemie, 2008
- Mechanism of the cytotoxicity of the diazoparaquinone antitumor antibiotic kinamycin FFree Radical Biology & Medicine, 2007
- Generation of New Landomycins with Altered Saccharide Patterns through Over‐expression of the Glycosyltransferase Gene lanGT3 in the Biosynthetic Gene Cluster of Landomycin A in Streptomyces cyanogenus S‐136ChemBioChem, 2006
- On the Acceptor Substrate of C‐Glycosyltransferase UrdGT2: Three Prejadomycin C‐Glycosides from an Engineered Mutant of Streptomyces globisporus 1912 ΔlndE(urdGT2)Angewandte Chemie, 2006
- Inactivation of gilGT, Encoding a C‐Glycosyltransferase, and gilOIII, Encoding a P450 Enzyme, Allows the Details of the Late Biosynthetic Pathway to Gilvocarcin V to be DelineatedChemBioChem, 2006